Chinese english Germany Japanese Korea

Kalium-[2S-(2α,5α,6α)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat

potassium [2S-(2alpha,5alpha,6alpha)]-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Struktur
74772-27-3
CAS-Nr.
74772-27-3
Bezeichnung:
Kalium-[2S-(2α,5α,6α)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat
Englisch Name:
potassium [2S-(2alpha,5alpha,6alpha)]-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Synonyma:
6β-Bromopenicillanic acid potassium salt;potassium [2S-(2alpha,5alpha,6alpha)]-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-bromo-3,3-dimethyl-7-oxo-, potassium salt, [2S-(2a,5a,6a)]- (9CI)
CBNumber:
CB0883300
Summenformel:
C8H9BrKNO3S
Molgewicht:
318.22926
MOL-Datei:
74772-27-3.mol
Request For Quotation

Kalium-[2S-(2α,5α,6α)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat Eigenschaften

Sicherheit

Kalium-[2S-(2α,5α,6α)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat Chemische Eigenschaften,Einsatz,Produktion Methoden

Kalium-[2S-(2α,5α,6α)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Kalium-[2S-(2α,5α,6α)]-6-brom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hu Bei Jiutian Bio-medical Technology CO.,Ltd 		027-88013699 17354350817
 Ryan@jiutian-bio.com China 7431 58
  • potassium [2S-(2alpha,5alpha,6alpha)]-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
  • 6β-Bromopenicillanic acid potassium salt
  • 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-bromo-3,3-dimethyl-7-oxo-, potassium salt, [2S-(2a,5a,6a)]- (9CI)
  • 74772-27-3
Copyright 2019 © ChemicalBook. All rights reserved